{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T20:59:18Z","timestamp":1784581158804,"version":"3.55.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.4158\/ep13417.or","type":"journal-article","created":{"date-parts":[[2014,2,11]],"date-time":"2014-02-11T21:09:27Z","timestamp":1392152967000},"page":"792-796","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":36,"title":["Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected"],"prefix":"10.1016","volume":"20","author":[{"suffix":"Jr","given":"Myrick C","family":"Shinall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen C","family":"Sol\u00f3rzano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP13417.OR_bb1","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2.","volume":"278","author":"Gutmann","year":"1997","journal-title":"JAMA"},{"key":"10.4158\/EP13417.OR_bb2","first-page":"43","article-title":"Genetic aspects of pheochromocytoma.","volume":"35","author":"Koch","year":"2001","journal-title":"Endocr Regul."},{"key":"10.4158\/EP13417.OR_bb3","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1158\/1078-0432.CCR-09-1237","article-title":"Clinical predictors and algorithm for the genetic diagnosis of pheochromocytoma patients.","volume":"15","author":"Erlic","year":"2009","journal-title":"Clin Cancer Res"},{"key":"10.4158\/EP13417.OR_bb4","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/j.1365-2362.2009.02174.x","article-title":"Neurofibromatosis type 1: should we screen for other genetic syndromes? A case report of co-existence with multiple endocrine neoplasia 2A.","volume":"39","author":"Gkaliagkousi","year":"2009","journal-title":"Eur J Clin Invest."},{"key":"10.4158\/EP13417.OR_bb5","doi-asserted-by":"crossref","first-page":"C13","DOI":"10.1530\/ERC-13-0046","article-title":"The NF1 gene: a frequent mutational target in sporadic pheochromocytomas and beyond.","volume":"20","author":"Welander","year":"2013","journal-title":"Endocr Relat Cancer."},{"key":"10.4158\/EP13417.OR_bb6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/GIM.0b013e3181bf15e3","article-title":"Clinical and genetic aspects of neurofibromatosis 1.","volume":"12","author":"Jett","year":"2010","journal-title":"Genet Med."},{"key":"10.4158\/EP13417.OR_bb7","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/S0022-5347(05)68171-2","article-title":"von Recklinghausen's disease and pheochromocytomas.","volume":"162","author":"Walther","year":"1999","journal-title":"J Urol"},{"key":"10.4158\/EP13417.OR_bb8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.4158\/EP.13.6.647","article-title":"Association of pheochromocytoma and ganglioneuroma: unusual finding in neurofibromatosis type 1.","volume":"13","author":"Mezitis","year":"2007","journal-title":"Endocr Pract"},{"key":"10.4158\/EP13417.OR_bb9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1477-7819-8-14","article-title":"Pheochromocytoma associated with neurofibromatosis type 1: concepts and current trends.","volume":"8","author":"Zografos","year":"2010","journal-title":"World J Surg Oncol."},{"key":"10.4158\/EP13417.OR_bb10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/BF03347397","article-title":"Neurofibromatosis type 1 associated with pheochromocytoma: a case report and a review of the literature. J Endocrinol Invest.","volume":"30","author":"Erem","year":"2007","journal-title":"J Endocrinol Invest."},{"key":"10.4158\/EP13417.OR_bb11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1445-5994.2010.02181.x","article-title":"A case of using cortical sparing adrenalectomy to manage bilateral phaeochromocytoma in neurofibromatosis type 1.","volume":"40","author":"Ku","year":"2010","journal-title":"Intern Med J."},{"key":"10.4158\/EP13417.OR_bb12","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jamcollsurg.2005.09.028","article-title":"Neurofibromatosis-associated pheochromocytoma.","volume":"202","author":"Lew","year":"2006","journal-title":"J Am Coll Surg."},{"key":"10.4158\/EP13417.OR_bb13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.jamcollsurg.2003.12.001","article-title":"Surgical management of hereditary pheochromocytoma","volume":"198","author":"Yip","year":"2004","journal-title":"J Am Coll Surg."},{"key":"10.4158\/EP13417.OR_bb14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-2796.1999.00533.x","article-title":"A patient with neurofibromatosis type 1 and watery diarrhoea syndrome due to a VIP-producing adrenal phaeochromocytoma","volume":"246","author":"Quarles Van Ufford-Mannesse","year":"1999","journal-title":"J Intern Med"},{"key":"10.4158\/EP13417.OR_bb15","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1056\/NEJMc066006","article-title":"Clinical and genetic characteristics of patients with neurofibromatosis type 1 and pheochromocytoma","volume":"354","author":"Bausch","year":"2006","journal-title":"N Engl J Med."},{"key":"10.4158\/EP13417.OR_bb16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/1476-4598-5-36","article-title":"Somatic deletion of the NF1 gene in a neurofibromatosis type 1-associated malignant melanoma demonstrated by digital PCR","volume":"5","author":"R\u00fcbben","year":"2006","journal-title":"Mol Cancer."},{"key":"10.4158\/EP13417.OR_bb17","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1210\/jc.2006-0780","article-title":"Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma","volume":"91","author":"Bausch","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13417.OR_bb18","first-page":"869","article-title":"Screening for phaeochromocytoma in which hypertensive patients? A semiological study of 2,585 patients, including 11 with phaeochromocytoma [in French].","volume":"10","author":"Plouin","year":"1981","journal-title":"Nouv Presse Med"},{"key":"10.4158\/EP13417.OR_bb19","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1196\/annals.1353.055","article-title":"Does the expression of c-kit (CD117) in neuroendocrine tumors represent a target for therapy?","volume":"1073","author":"Koch","year":"2006","journal-title":"Ann N Y Acad Sci"},{"key":"10.4158\/EP13417.OR_bb20","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jc.2006-2833","article-title":"Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1.","volume":"92","author":"Bausch","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4158\/EP13417.OR_bb21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00403-010-1090-z","article-title":"Neurofibromatosis type 1 (NF1) and pheochromocytoma:prevalence, clinical and cardiovascular aspects.","volume":"303","author":"Zinnamosca","year":"2011","journal-title":"Arch Dermatol Res."},{"key":"10.4158\/EP13417.OR_bb22","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/j.surg.2009.09.013","article-title":"Biopsy of pheochromocytomas and paragangliomas:potential for disaster","volume":"146","author":"Vanderveen","year":"2009","journal-title":"Surgery"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20412480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20412480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/J570311084X4J2H7.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:57:54Z","timestamp":1761515874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20412480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S1530891X20412480"],"URL":"https:\/\/doi.org\/10.4158\/ep13417.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pheochromocytoma in Neurofibromatosis Type 1: When Should it Be Suspected","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP13417.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}